SEC Form 4 · accession 0001179110-17-011806
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard S Levy
Director
Period of report
Aug 23, 2017
Accepted (ET)
Aug 24, 2017 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157601
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 23, 2017 | P | 100 | $16.08 | A | 7,200 | D | |
| Common Stock | Aug 23, 2017 | P | 100 | $16.11 | A | 7,300 | D | |
| Common Stock | Aug 23, 2017 | P | 1,793 | $16.12 | A | 9,093 | D | |
| Common Stock | Aug 23, 2017 | P | 7 | $16.25 | A | 9,100 | D |
Table II — derivative securities
No Table II lines on this filing.